Nuwellis, Inc. (NUWE) vs ThermoGenesis Holdings, Inc. (THMO)

Nuwellis, Inc. and ThermoGenesis Holdings, Inc. are both Medical Devices companies. Nuwellis, Inc. is the larger, with a market value of $2.0M against $1.1M — 1.8× the size. Nuwellis, Inc. grew revenue faster over the last twelve months: 8.36% against −7.53%. Nuwellis, Inc. has the higher net margin (−125.6% vs −153.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Nuwellis, Inc. leads on 8 and ThermoGenesis Holdings, Inc. on 6.

Valuation

Metric NUWE THMO Medical Devices median
P/E n/m n/m 23.22
P/S 0.01 n/m 2.34
P/B n/m n/m 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 0.01 0.84 2.24
Earnings yield (24,106.36%) 0.00% (10.09%)
Free cash flow yield (12,722.26%) 0.00% (8.47%)

Profitability

Metric NUWE THMO Medical Devices median
Gross margin 69.69% 21.10% 56.01%
Operating margin (142.87%) (84.52%) (15.03%)
Net margin (125.57%) (153.43%) (20.40%)
Free cash flow margin (140.67%) (47.79%) (7.24%)
Return on equity 205.50% (751.34%) (15.32%)
Return on assets (123.52%) (98.83%) (19.72%)
Return on invested capital 0.00% 0.00% (10.33%)

Growth

Metric NUWE THMO Medical Devices median
Revenue growth (TTM) 8.36% (7.53%) 8.80%
EPS growth (last fiscal year) 92.81% 62.89% 29.03%
Revenue growth, 5-year CAGR 2.14% (0.47%) 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NUWE THMO Medical Devices median
Debt to equity 0.00 0.00 0.07
Current ratio 1.97 0.52 2.50
Net debt to EBITDA 0.10 (2.38) 0.49

Dividend

Metric NUWE THMO Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric NUWE THMO Medical Devices median
Market cap 2.01m 1.11m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack